0.34
0.34 (-0.14%)
As of Nov 29, 2023
Timber Pharmaceuticals, Inc. [TMBR]
Source:
Company Overview
Timber Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases.
| Country | United States |
| Headquarters | warren, new jersey |
| Phone Number | (917) 697-3130 |
| Industry | manufacturing |
| CEO | John Koconis |
| Website | www.timberpharma.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0 |
| Operating Profit | $-4 |
| Net Income | $-4.1 |
| Net Cash | $-6.6 |
Profit Ratios
| Gross Margin | |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -59.7% |
| Profit as % of Stockholder Equity | 155% |
Management Effectiveness
| Return on Equity | 155% |
| Return on Assets | -122.2% |
| Turnover Ratio | 0% |
| EBITA |
Balance Sheet and Cash Flow Measures
| Total Assets | $3.3 |
| Total Liabilities | $5.9 |
| Operating Cash Flow | $-6.6 |
| Investing Cash Flow | $-0 |
| Financing Cash Flow | $0 |
